alexa Leandro Bueno Bergantin | Universidade Federal de São
ISSN: 2472-100X

Journal of Pediatric Neurology and Medicine
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Leandro Bueno Bergantin

Leandro Bueno Bergantin Leandro Bueno Bergantin
Department of Pharmacology Rua Pedro de Toledo
Universidade Federal de São Paulo

Dr. Bergantin received his academic education at EPM-UNIFESP (Brazil) and UAM (Spain): Degree in biomedicine (2008), MSc (2010) and PhD (2014). His research work solved the enigma of the paradoxical effects produced by L-type Ca2+ channel blockers (TOP 25 Hottest Articles - Biochemistry, Genetics and Molecular Biology - Cell Calcium - TOP 1 July to September 2013/ TOP 5 October to December 2013/ TOP 1 January to December 2013 full year/TOP 6 January to March 2014). Since 1975, several clinical and experimental studies have reported that acute and chronic administration of L-type Ca2+ channel blockers (CCB), such as nifedipine, produces reduction in arterial pressure associated with a paradoxical increase of sympathetic activity. Despite this sympathetic hyperactivity has been initially attributed to adjust reflex of arterial pressure, the cellular and molecular mechanisms involved in this apparent sympathomimetic effect of the Ltype CCB remained unclear for decades. In 2013, Dr. Bergantin and collaborators discovered that this paradoxical increase in sympathetic activity produced by L-type CCB is due to interaction of the Ca2+/cAMP signaling pathways. Then, the pharmacological manipulation of the Ca2+/cAMP interaction produced by combination of the L-type CCB used in the antihypertensive therapy, and cAMP accumulating compounds used in the antidepressive therapy, could represent a potential cardiovascular risk for hypertensive patients due to increase in sympathetic activity. In contrast, this pharmacological manipulation could be a new therapeutic strategy for increasing neurotransmission in psychiatric disorders, and producing neuroprotection in the neurodegenerative diseases (Bergantin and Caricati-Neto, 2016 Eur J Pharmacol; Caricati-Neto et al., 2015 Pharm Res Perspect). Dr. Bergantin has published several articles in international journals (> 30), book chapters and an international book. He is member of several editorial boards of international journals (> 40, including editor-in-chief of 2 international journals). Dr. Bergantin has been frequently invited (every week) to be honorable guest (speaker) in international conferences.

Research Interest

Neuropsychopharmacology, autonomic and cardiovascular pharmacology, cell signaling mediated by Ca2+ and cAM.



The Second Messengers Ca2+ and camp as Potential Therapeutic Targets for the Control of Cancer Progression
Paolo Ruggero Errante, Francisco Sandro Menezes-Rodrigues, Alberto Andrade Leite, Afonso Caricati-Neto and Leandro Bueno Bergantin*
Editorial: Adv Cancer Prev 2: e105
DOI: 10.4172/2472-0429.1000e105
Extracellular Cyclic AMP/Adenosine Signaling Pathway: A Potential Pharmacological Target for Therapeutic Intervention in Chronic Lymphocytic Leukemia
Francisco Sandro Menezes-Rodrigues, Paolo Ruggero Errante, Afonso Caricati-Neto and Leandro Bueno Bergantin
Editorial: Adv Cancer Prev 2: e104
DOI: 10.4172/2472-0429.1000e104
Sudden Unexpected Death in Parkinson’s Disease and the Pharmacological Modulation of the Ca2+/cAMP Signaling Interaction: A Shot of Good News
Afonso Caricati-Neto1, Fúlvio Alexandre Scorza2 ,Carla Alessandra Scorza2, Roberta Monterazzo Cysneiros3, Francisco Sandro Menezes- Rodrigues1, and Leandro Bueno Bergantin1*
Short Communication: Brain Disord Ther 2017, 6:231
DOI: 10.4172/2168-975X.1000231
Insights for the Inhibition of Cancer Progression: Revisiting Ca2+ and Camp Signalling Pathways
Paolo Ruggero Errante, Afonso Caricati-Neto and Leandro Bueno Bergantin
Editorial: Adv Cancer Prev 2: e103
DOI: 10.4172/2472-0429.1000e103
A 4-Decade Enigma, Two Researchers and a Wonderful History
Leandro Bueno Bergantin and Afonso Caricati-Neto
Editorial: Fam Med Med Sci Res 2017, 6:e109
DOI: 10.4172/2327-4972.1000e109
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version